A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.

For decades, a piece of the puzzle has been missing in the study of Crohn’s disease and how it develops in the body. But a recent discovery from researchers at the UC San Diego School of Medicine in ...

Heightened immune response to flagellins in commensal gut microbes predicted future CD in healthy first-degree relatives of patients.

UC San Diego researchers have settled a decades-long debate surrounding the role of the first Crohn's disease gene to be associated with a heightened risk for developing the auto-immune condition.

As in symptomatic Crohn’s disease, inflammation is occurring in the digestive tract, but symptoms may be subtle or even absent, leaving people with the condition unaware that anything is wrong. It can ...

Fat is more complicated than we thought. Once considered just a bag of calories, scientists now know that our fat—aka adipose tissue—doesn't just squirrel away energy; it also sends and receives ...

Scientists saw great benefits from a type of intermittent fasting in improving Crohn’s disease symptoms. Klaus Vedfelt/Getty Images Crohn’s disease is a chronic condition that affects the intestines.

A new clinical trial suggests that changing when you eat could make a meaningful difference for people living with Crohn’s disease. Researchers found that time-restricted feeding, a form of ...